Related Experiment Video
Updated: Apr 10, 2026
11:02
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.9K
[Neoadjuvant or Adjuvant Chemotherapy for Bladder Cancer?]
M C Hupe1, M W Kramer1, M A Kuczyk1
1Klinik für Urologie und Urologische Onkologie, Medizinische Hochschule Hannover, Hannover.
Aktuelle Urologie
|June 17, 2015
Summary
Metastatic bladder cancer has poor survival rates. Chemotherapy, including neoadjuvant and adjuvant options, can improve outcomes, with gemcitabine and cisplatin as a standard first-line treatment for advanced urothelial carcinoma.
Area of Science:
- Uro-oncology
- Medical oncology
- Cancer research
Background:
- Advanced urothelial carcinoma of the bladder presents a significant metastatic risk.
- Prognosis for metastatic bladder cancer is poor, often less than one year without treatment.
- Chemotherapy plays a crucial role in managing advanced disease.
Purpose of the Study:
- To review current therapeutic strategies for advanced urothelial carcinoma.
- To highlight the role of neoadjuvant and adjuvant chemotherapy.
- To discuss first- and second-line treatment options for metastatic bladder cancer.
Main Methods:
- Literature review of studies on advanced urothelial carcinoma treatment.
- Analysis of chemotherapy regimens, including neoadjuvant, adjuvant, and metastatic settings.
- Evaluation of survival data and toxicity profiles of different treatments.
Main Results:
- Neoadjuvant chemotherapy can reduce tumor burden and mortality risk.
- Adjuvant chemotherapy benefits are most evident in patients with lymph node-positive metastases.
- Gemcitabine plus cisplatin is the standard first-line regimen for metastatic disease due to lower toxicity than MVAC.
- Vinflunine is the sole approved agent for second-line treatment.
Conclusions:
- Chemotherapy significantly impacts survival in advanced urothelial carcinoma.
- Treatment selection depends on disease stage, metastatic status, and prior therapies.
- Optimized chemotherapy regimens improve patient outcomes in metastatic bladder cancer.
Related Concept Videos
01:30Urinary Tract Calculi III: Medical Management
349
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
349
01:25Urinary Tract Calculi VI: Surgical Management
886
Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
886
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
879
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
879
01:22Imaging Studies VI: Voiding Cystourethrography and Cystography
4.0K
Voiding Cystourethrography (VCUG) and Cystography are specialized radiographic procedures used to examine the structure and function of the bladder and urethra.Voiding Cystourethrography (VCUG)A Voiding Cystourethrogram (VCUG) is a diagnostic imaging procedure that assesses the anatomy and function of the lower urinary tract. It focuses on the bladder, bladder neck, and urethra, helping detect abnormalities such as vesicoureteral reflux (VUR)—the backward or reverse flow of urine into the...
4.0K
01:26Kidney Transplant II: Surgical Procedure
827
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
827
01:23Urinary Bladder
4.5K
The urinary bladder is a hollow, muscular sac that temporarily stores urine before it is expelled from the body. It can hold approximately 600 mL of urine prior to micturition. The bladder is retroperitoneal and located behind the pubic symphysis in the pelvic floor.
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
4.5K